Regeneron Pharmaceuticals, Inc. (REGN)
805.02
-14.07
(-1.72%)
USD |
NASDAQ |
Oct 23, 16:00
805.07
+0.05
(+0.01%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price to Book Value : 2.625 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.625 |
| October 22, 2026 | 2.671 |
| October 21, 2026 | 2.627 |
| October 20, 2026 | 2.633 |
| October 19, 2026 | 2.55 |
| October 16, 2026 | 2.578 |
| October 15, 2026 | 2.597 |
| October 14, 2026 | 2.538 |
| October 13, 2026 | 2.456 |
| October 12, 2026 | 2.487 |
| October 09, 2026 | 2.434 |
| October 08, 2026 | 2.412 |
| October 07, 2026 | 2.420 |
| October 06, 2026 | 2.409 |
| October 05, 2026 | 2.369 |
| October 02, 2026 | 2.397 |
| October 01, 2026 | 2.396 |
| September 30, 2026 | 2.472 |
| September 29, 2026 | 2.447 |
| September 28, 2026 | 2.453 |
| September 25, 2026 | 2.570 |
| September 24, 2026 | 2.596 |
| September 23, 2026 | 2.614 |
| September 22, 2026 | 2.621 |
| September 21, 2026 | 2.603 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.559 |
| September 17, 2026 | 2.574 |
| September 16, 2026 | 2.526 |
| September 15, 2026 | 2.524 |
| September 14, 2026 | 2.588 |
| September 11, 2026 | 2.548 |
| September 10, 2026 | 2.586 |
| September 09, 2026 | 2.634 |
| September 08, 2026 | 2.642 |
| September 04, 2026 | 2.699 |
| September 03, 2026 | 2.750 |
| September 02, 2026 | 2.778 |
| September 01, 2026 | 2.686 |
| August 31, 2026 | 2.606 |
| August 28, 2026 | 2.590 |
| August 27, 2026 | 2.634 |
| August 26, 2026 | 2.657 |
| August 25, 2026 | 2.718 |
| August 24, 2026 | 2.702 |
| August 21, 2026 | 2.720 |
| August 20, 2026 | 2.695 |
| August 19, 2026 | 2.742 |
| August 18, 2026 | 2.642 |
| August 17, 2026 | 2.628 |
| August 14, 2026 | 2.620 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amgen, Inc. | 20.32 |
| AbbVie, Inc. | -- |
| Biogen, Inc. | 1.964 |
| Incyte Corp. | 3.665 |
| Vertex Pharmaceuticals, Inc. | 6.556 |
Price to Book Value Related Metrics
| PE Ratio | 19.90 |
| PS Ratio | 5.55 |
| PEG Ratio | 10.18 |
| Price to Free Cash Flow | 24.12 |
| Price | 805.02 |
| Earnings Yield | 5.03% |
| Market Cap | 83.24B |
| PEGY Ratio | 8.244 |
| Operating PE Ratio | 20.66 |
| Normalized PE Ratio | 18.77 |